AMR demands sustained commitment beyond conventional market incentives. It requires founders with deep personal conviction ...

The outcome of the study was just one setback reported by Vertex as it updated investors on its second-quarter results, ...

The Gates Foundation is doubling down on its support for women's health research, pumping $2.5 billion between now and the ...

It's a pivotal moment for cell therapy. New trials, breakthrough data, major acquisitions and regulatory shifts are ...

Nalvee marks a return to the market for a dydrogesterone-only product after an absence of 17 years, and can be used in ...

Around 240,000 people are expected to be offered Mounjaro over the next three years, according to NICE, which has recommended ...

In a post-Congress conversation, web editor Nicole Raleigh spoke with Dr Corina Dutcus, senior vice president and oncology global clinical development lead at Eisai, who discussed the data and the ...

Digital health company Noom has started offering lower doses of GLP-1 agonist semaglutide, the active ingredient in Novo Nordisk's weight-loss drug Wegovy, at a knock-down price. The 'microdose' ...

Don't fall behind. Take a step toward becoming indispensable to your organization by attending our no-cost* LEAN Cell & Gene Boston Summit on Monday, September 22, conveniently planned just one day ...

Grant funding calls are often over-subscribed and success rates can be low. Excellent applications sometimes fail to be ...

At HLTH Europe, Deep Dive editor Eloise McLennan sat down with Scott Honken, chief commercial officer at WeightWatchers, to ...

Pharma 4.0 is no longer a future ambition; it’s the baseline. The ability to operate with real-time data, integrated systems, ...